For Women, Poor Sleep Associated with Unhealthy Eating
Research published Monday in the Journal of the American Heart Association found an association between poor sleep quality and higher calorie intake including increased consumption of sugar, saturated fat and caffeine. The year-long study of a racially and ethnically diverse group of 495 women age 20 to 76 tracked sleep quality, ability to fall asleep and insomnia. Women who didn’t get enough sleep or had poor-quality sleep consumed an extra 500 to 800 calories per day on average.
The results are concerning because women are at high risk for obesity and sleep disorders, both of which are associated with an increased risk of heart disease. While poor sleep has been previously associated with heart disease, this study expands limited data on the dietary connection. Scientists believe that poor sleep stimulates hunger and/or suppresses hormones that signal fullness.
Generic Drug Execs Pleads Guilty to Price Fixing
On Friday, the U.S. Department of Justice announced that Hector Armando Kellum, a former senior executive with New Jersey-based generic drug manufacturer Sandoz, had pleaded guilty to conspiring with other generic drug executives to "to fix prices, rig bids, and allocate customers for generic drugs" from 2013-15. Kellum is the fourth executive charged and the third to plead guilty in the Justice Department’s ongoing investigation into generic price-fixing.
Two Sandoz drugs were involved: eczema and psoriasis drug clobetasol, and nystatin triamcinolone cream, an antifungal with a corticosteroid. Sandoz, a division of Swiss multinational pharmaceutical giant Novartis Group, is a global leader in the generics industry with annual sales topping $10 billion. Kellum is the first executive from a major generic drug manufacturer to be charged. The other three executives were from fairly small companies.
According to Reuters, sharply increasing U.S. drug prices, including drugs that have already been on the market for years, has become a political issue.